Guardant Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Guardant Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2018 to Q3 2024.
  • Guardant Health, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $500K, a 28.6% decline year-over-year.
  • Guardant Health, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $2.4M, a 14.3% decline year-over-year.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2023 was $2.7M, a 8% increase from 2022.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2022 was $2.5M, a 31.6% increase from 2021.
  • Guardant Health, Inc. annual Amortization of Intangible Assets for 2021 was $1.9M, a 5.56% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.4M $500K -$200K -28.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.6M $600K -$100K -14.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $2.7M $700K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.7M $600K -$100K -14.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $2.8M $700K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $2.8M $700K +$100K +16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.7M $700K +$200K +40% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.5M $700K +$300K +75% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $2.2M $700K +$200K +40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $2M $600K +$100K +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.9M $500K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.9M $400K -$200K -33.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $2.1M $500K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.1M $500K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.1M $500K +$300K +150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.8M $600K +$300K +100% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.5M $500K +$300K +150% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.2M $500K +$300K +150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $900K $200K +$200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $700K $300K +$994K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$294K $200K -$66K -24.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$228K $200K -$39K -16.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$189K $0 -$189K -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $0 -$694K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $266K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $239K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $189K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.